According to modern concepts, the genus Hyssopus L. includes seven plant species (Hyssopus ambiguus (Trautv.) Iljin ex Prochorov. & Lebel; Hyssopus cuspidatus Boriss; Hyssopus latilabiatus C.Y.Wu & H.W. Li; Hyssopus macranthus Boriss.; Hyssopus officinalis L.; Hyssopus seravschanicus (Dubj.) Pazij; Hyssopus subulifolius (Rech.f.) Rech.f.). The plants are rich in various groups of biologically active substances with a wide spectrum of pharmacological action. This review presents a modern comprehensive overview of the botanical research, extraction methods, chemical composition and pharmacological activity of plants of the genus Hyssopus L. As a result of the review, it was established that the chemical composition of plant extracts of the genus Hyssopus L. depends on various factors (place of growth, weather conditions, chemotypes, extraction methods, etc.). For the further use of the plants, the extraction methods and low-molecular metabolites isolated from them (mono- and sesquiterpenoids, flavonoids, alkaloids, etc.) are discussed. The data from the review provide an assessment of the relevance.

This review is devoted to a systematic analysis of studies aimed at investigating plant extracts, essential oils and phytochemical compounds capable of inhibiting Streptococcus mutans biofilm formation. This paper investigates the effect of extracts, essential oils and individual plant compounds on inhibiting the biofilm formation of Streptococcus mutans, one of the major pathogens responsible for the development of dental caries. Using cultural microbiology and molecular biology techniques, the authors describe the mechanisms by which plant samples reduce Streptococcus mutans adhesion and growth. The results show that several plant components have antibacterial properties, contributing to the reduction of Streptococcus mutans colony numbers and inhibiting the synthesis of extract-exopolysaccharide matrices required for biofilm formation. This work highlights the potential of botanicals in inhibiting Streptococcus mutans biofilm formation, which can be applied as natural antimicrobial agents in the prevention and treatment of dental diseases. Views on the use of these plant extracts and their components in dental preparations such as toothpastes, rinses and gels aimed at preventing dental caries are evaluated. The review shows the relevance of the research to optimizing the use of plant extracts, essential oils, individual compounds and their active actions in the control of Streptococcus mutans biofilms.

According to current taxonomic consensus, the genus Fragaria L. (family Rosaceae) comprises nine recognized species: Fragaria × ananassa (Duchartre ex Weston) Duchesne ex Rozier, Fragaria bucharica Losinsk., Fragaria viridis subsp. campestris (Steven) Pael., Fragaria chiloensis (L.) Mill., Fragaria moschata Duchesne ex Weston, Fragaria orientalis Losinsk., Fragaria vesca L., Fragaria virginiana Mill., and Fragaria viridis Duchartre. Within the flora of Kazakhstan, two species are of particular significance: F. vesca L. and F. viridis Weston. The genus Fragaria L. is notable for its high content of diverse classes of biologically active compounds, which exhibit a broad spectrum of pharmacological and physiological activities. This review focuses on two Fragaria species native to the flora of Kazakhstan: F. vesca L. and F. viridis Weston. It summarizes recent advances in their botanical characterization, phytochemical profiling, extraction methodologies, and biological activities. Available evidence indicates that the phytochemical composition of extracts obtained from these species is modulated by a range of environmental and biological factors. These include habitat conditions, climate variability, chemotypic diversity, and the specific extraction protocols applied. Particular emphasis is placed on modern extraction techniques and the identification of low-molecular-weight metabolites. These include anthocyanins, volatile organic compounds, flavonoids, and phenolic acids, which contribute significantly to the observed biological effects. The review findings support the relevance of continued research into the potential application of these species as sources for the development of novel therapeutic and prophylactic agents. In addition, they highlight their promise for use in the formulation of biologically active compounds intended for food supplements and cosmetic products.

Dental caries is a major global health concern, with Streptococcus mutans playing a key role in biofilm formation and acid production, which lead to enamel demineralization. Natural products, particularly plant-derived extracts, offer promising alternatives to conventional antibacterial agents. This study aimed to analyze the chemical composition of Ferula varia 70% ethanol extract (FVE) and evaluate its potential to inhibit biofilm formation by S. mutans. The aerial parts of F. varia were extracted with 70% ethanol and analyzed using LC-UV-ESI-MS/MS to determine the chemical profile. The anti-biofilm activity of FVE was evaluated using a crystal violet assay against S. mutans. Phytochemical analysis identified 14 compounds, including major phenolic acids (e.g., chlorogenic acid, gallic acid) and flavonoids (e.g., isoquercitrin, isorhamnetin-3-O-glucoside). FVE exhibited significant, dose-dependent inhibition of S. mutans biofilm formation. Importantly, the FVE concentration of 5 mg/mL inhibited S. mutans biofilm development by 100%. The potent antibiofilm activity of FVE against S. mutans is likely due to the synergistic action of its rich content of phenolic acids and flavonoids, which possess known anti-virulence properties. These findings support the potential use of FVE as a natural ingredient in oral hygiene products to prevent dental plaque and caries.

Background/Objectives: Ferula varia Trautv. is a promising medicinal plant of the Apiaceae family and a potential source of biologically active secondary metabolites. The present study aimed to investigate the phytochemical composition and biological activities of F. varia root extract. Methods: The non-volatile compounds were characterized using high-performance liquid chromatography coupled with mass spectrometry (HPLC–QTOF–ESI-MS/MS) method. Furthermore, the total phenolic and flavonoid contents (TPC and TFC), antioxidant activity, and antimicrobial potential of the extract were evaluated using spectrophotometric and microdilution assays. Results: HPLC-ESI-QTOF-MS/MS analysis enabled the tentative identification of 25 metabolites in the F. varia root extract, predominantly sesquiterpene coumarins together with organic acids, phenolic acids, coumarins, sesquiterpene esters, and prenylated aromatic compounds. The extract contained 30.06 ± 3.00 mg GAE/g_extr of total phenolics and 1.42 ± 0.04 mg RuE/g_extr of total flavonoids. Antioxidant assays revealed Trolox equivalent antioxidant capacity (TEAC), total antioxidant capacity (TAC), ferric reducing antioxidant power (FRAP) values of 0.10 ± 0.00 mM, 110.31 ± 4.94 mg AsAE/g_extr, and 21.95 ± 0.00 mg TE/g_extr, respectively, while the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay showed weak radical scavenging activity (IC₅₀ > 1 mg/mL). The extract also demonstrated stronger antimicrobial activity against yeasts than against Gram-positive and Gram-negative bacteria, with minimal inhibitory concentration values ranging from 2.5 to 5 mg/mL and 10–20 mg/mL, respectively. Conclusions: These findings indicate that F. varia roots are a promising source of bioactive compounds exhibiting antioxidant and antimicrobial potential.